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Background: Overweight and obesity are components of a defined cluster of risk factors for non-communicable
diseases, once problems for only the high-income countries, in recent days became rampant in developing countries.
Despite the lack of extensive data on metabolic and cardio vascular disorders in Ethiopia, the prevalence of obesity
among young adults (15–24 years), in a cross sectional study conducted in 1997, was 0.7% for men and 6% for women.
The prevalence of hypertension (HTN) was found to be 7.1% of the population. The objective of this study was to see
the prevalence and association of overweight, obesity and HTN and to check if there was any agreement among the
various anthropometric measurements in detecting overweight and obesity.
Methods: This cross-sectional study was conducted in Gondar city, Northwest Ethiopia. A total of 68 participants with
age >18 year were randomly selected and included. Data were collected using questionnaires and through physical
measurements of weight, height and blood pressure, using the WHO recommendations.
Result: The prevalence of hypertension was 13.3% (9/68). The prevalence of overweight based on calculated body
mass index (BMI) was 32.4% (22/68) while the prevalence of obesity was 16.2% (11/68). Body fat percentage (BFP)
effectively classified all of the ‘overweight’ and ‘obese’ values according to the BMI as ‘overweight/obese’ (P = 0.016).
Risk level classification with waist circumference enabled to correctly classify most (90.9%) and all of the ‘overweight’
and ‘obese’ BMI values as ‘increased risk/substantially increased risk’ (P < 0.001). Similarly, waist-to-height ratio (WHtR)
was able to classify all ‘overweight’ and ‘obese’ BMI values as ‘increased risk/substantially increased risk’ (P < 0.001).
Conclusion: In conclusion, the current study was able to detect a high prevalence of overweight, obesity, and HTN
among adult population in Gondar town. There is a prevalent high level of general adiposity and central obesity.
WHtR and BFP were the most efficient measurements to identify all ‘high risk’ groups of individuals as ‘high risk’
irrespective of their gender. Further study is recommended to elucidate the risk factors and complications of obesity
and overweight in the study area and beyond.
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Globally cardiovascular diseases account for approximately
17 million deaths a year, nearly one third of the total [1].
Of these, every year, complications of hypertension (HTN)
account for 9.4 million deaths worldwide [2]. It is also
believed that HTN is responsible for at least 45% and 51%
of deaths due to heart disease and stroke, respectively [1].
In 2008, worldwide, approximately 40% of adults aged 25
and above had been diagnosed with HTN [3,4].
According to the World Health Organization (WHO),
the global prevalence of overweight and obesity in 2008
among adults was more than 1.4 billion and more than
half a billion, respectively. It is believed that 65% of the
world’s population lives in a country where overweight
and obesity kills more people than underweight. Each
year, it is estimated that at least 2.8 million people die as
a result of being overweight or obese [5].
Overweight and obesity are components of a defined
cluster of risk factors for non-communicable diseases,
once problems for only the high-income countries, in re-
cent days became rampant in developing countries. Major
co-morbidities associated with these conditions include
cardiovascular disease (CVD), cerebrovascular disease,
type 2 diabetes mellitus (DM), atherogenic dyslipidaemia
and certain types of cancer [6]. Globally, 44% of DM, 23%
of ischaemic heart disease and 7–41% of certain cancers
are attributable to overweight and obesity [5].
Despite the lack of extensive data on metabolic and
CVD in Ethiopia, in 1997, a cross sectional study con-
ducted in 1,436 (851 females and 585 males) young people
and the prevalence of obesity was 0.7% for men and 6%
for women [7]. The prevalence of HTN was found to be
7.1% of the population [7]. On the other hand, in 2008 a
community-based study in Addis Ababa showed that 20%
of men and 38% of women were overweight and 10.8% of
these women were obese. Besides, 31.5% of men and
28.9% of women had HTN [8] indicating a silent but rad-
ical transition of metabolic and cardiovascular disorders in
Ethiopia in the past few decades. The objective of this
study was therefore to evaluate the prevalence and associ-
ation of overweight, obesity and HTN and validate if there
was any agreement among the various anthropometric
measurements in detecting overweight and obesity.
Several anthropometric measures have been used to as-
sess abnormal body fat distribution, including body mass
index (BMI), waist circumference (WC) and waist-to-hip
ratio (WHR) [9]. However, these measurements have been
shown to correlate differently with CVD risk [10]. Even
though BMI is used frequently as a measure of adiposity
in epidemiologic studies, there is a claim that using BMI
alone is not the most accurate measure of increased CVD
risk rather WC and WHR [10]. On top of these, most of
the existing recommendations are derived mainly from
data obtained in Western populations underlining thenecessity of country specific assessment of associations
between measures of adiposity and CVD risk factors for
prevention efforts.
Methods
Study design and subjects
This cross-sectional study was conducted in Gondar city,
Northwest Ethiopia as a section of a dietary intake and
nutritional status survey described elsewhere [11]. Gondar
is a zonal capital city located 750kms north of Addis
Ababa in Amhara Region. Based on the 2007 national
census conducted by the Central Statistical Agency of
Ethiopia, Gondar has a total population of 207,044, of
whom 98,120 are men and 108,924 women. All partici-
pants with age >18 year and not acutely ill at the time of
survey were randomly selected and included.
Data collection
Data were collected using questionnaires and through
physical measurements of weight, height and blood pres-
sure (BP), using the WHO recommendations. Weight and
height were measured with participants standing without
shoes and wearing light clothing. Participants stood up-
right with the head in Frankfort plane for height measure-
ment. Body weight (kg) was measured using an electronic
scale to the nearest 10 g, and standing height was mea-
sured using a wall stadiometer to the nearest 0.1 cm. BMI
was calculated as body weight (kg)/height (m2).
The subjects were then classified into four groups
according to the WHO BMI cut-offs [9]:
“Underweight”: BMI <18.5 kg/m2
“Normal weight”: BMI =18.5 – 24.9 kg/m2
“Overweight”: BMI =25 – 29.9 kg/m2
“Obese”: BMI ≥30 kg/m2
Waist and hip circumferences were measured with a
flexible steel metric tape at the nearest 0.5 cm. Waist
circumference (WC) was measured midway between the
lower rib margin and the iliac crest in the horizontal plane.
While the subjects were standing, hip circumference (HC)
was measured at the point yielding the maximum circum-
ference over the buttocks using a tape measure to measure
to the nearest 0.5 cm. Waist-to-hip ratio (WHR) was ob-
tained by dividing the WC measurement with that of HC.
Similarly, the waist-to-height ratio (WHtR) was obtained
by dividing the WC value to the height of the individual.
Gender specific WC values denoting risk of metabolic
complications [9]:
“Not increased”: <80 cm females, <94 cm males
“Increased”: 80–87.9 cm females, 94–101.9 cm males
“Substantially increased”: ≥88 cm females, ≥102 cm
males
Table 1 Age and gender adjusted BFP cut off values as
estimated for African Americans
Age (years) BMI (kg/m2) Body fat (%)
Female Male
20-39 <18.5 <20 <8
18.5-24.9 20-31.9 8-19.9
25-29.9 32-37.9 20-25.9
> = 30 > = 38 > = 26
40-59 <18.5 <21 <9
18.5-24.9 21-33.9 9-21.9
25-29.9 34-38.9 22-26.9
> = 30 > = 39 > = 27
60-79 <18.5 <23 <11
18.5-24.9 23-34.9 11-22.9
25-29.9 35-40.9 23-28.9
> = 30 > = 41 > = 29
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complications [9]:
“Low risk” : <0.85 for females, <0.90 for males
“Increased risk” : > = 0.85 for females, > = 90 for males
WHtR values for both sexes denoting risk of metabolic
complications [12]:
“Low adiposity” : <0.40
“Low risk”: 0.40-0.499
“Increased risk”: 0.50-0.59
“Substantially increased risk”: > = 0.60
Body fat composition (body fat percentage and visceral
fat level) was assessed by means of Karada Scan™ Body
Composition Monitor (Model HBF-358-BW, Omron
healthcare Co., Ltd. Kyoto, Japan). The age and gender
adjusted body fat percentage (BFP) cut off values are as
summarized in the following table as calculated for African
Americans by Gallagher et al. [13]:
The subjects were then classified into three groups
based on the visceral fat level (VFL) using cut off values
provided with Kaladar™ Scan”
“Low risk”: 1–9,
“High risk”: 10–14
“Very high risk”: 15–30
BP was measured, according to WHO guidelines, in a
sitting position after the participant rested for at least
5 min. Three measurements were taken with intervals of
3 min between consecutive measurements. In addition,
participants were asked whether they were taking any
medications for the treatment of hypertension. Average
systolic BP (SBP) and diastolic BP (DBP) were determined
from the second and third measurements. Hypertension
was defined as SBP > =140 mm Hg or DBP > =90 mm Hg
or self reported use of antihypertensive medication, with
adaptation of the recent WHO definitions [14].
Ethical considerations
The study was conducted after ethical approval was ob-
tained from Institutional Review Board of the University
of Gondar and after informed consent was obtained
from study participants. Participants with elevated blood
pressure were advised and referred to the University of
Gondar Hospital for proper management and follow up.
Statistical analysis
Statistical Software for Social Sciences (SPSS) version 20
and Stata12 were used to analyze the data. Frequency
distributions of sociodemographic characteristics and
anthropometric measurements of the study populationwere determined by performing cross-tabulations of a
variety of variables across gender and were expressed in
percentage (%). Pearson’s chi square test was used to
evaluate the differences in the distribution of categorical
variables for study groups. The mean ± SD of anthropo-
metric measurements were compared among men and
women by one-way ANOVA. Post-hoc Tukey test was
used to determine which pairs of means differ signifi-
cantly. In all cases, P values less than 0.05 were consid-
ered statistically significant.
Result
A total of 68 (Male = 29, Female = 39) adults were
included in this study with mean (±SD, range) age of
38.76 (±10.72, 21–70) years (Table 1). Other sociodemo-
graphic characteristics and dietary intake pattern of the
participants was published elsewhere [11]. The preva-
lence of HTN, based on raised SBP or DBP, was 13.3%
(9/68). The prevalence among men and women was
17.2% (5/29) and 10.3% (4/39), respectively. On the
other hand, the prevalence of pre-HTN (SBP > =130 mm
Hg or DBP > =80 mm Hg) 38.2% (26/68).
Table 2 summarizes the various anthropometric and
blood pressure measurements of the participants based on
their gender. While the prevalence of overweight in the
current study based on measurements of the BMI was
32.4% (22/68), the prevalence of obesity was 16.2% (11/68).
Based on the measurements from the WC of individual
participants the risk of developing CVDs was rated to be
increased in 22% (15/68) and substantially increased in
51.5% (35/68). Similarly, based on WHR 73.5% (50/68) of
the individuals were found to have increased risks of de-
veloping CVDs. Risk classification with WHtR showed
that 51.5% (35/68) and 36.7% (25/68) of the participants
Table 2 Distribution of age groups and anthropometric measurements tabulated against sex of participants,
N = 68 (M = 29, F = 39), Gondar, Ethiopia
Sex P value
Male N (%) Female N (%) Total (%)
Age (years) 20-39 15 (51.7) 21 (53.8) 36 (52.9) 0.69
40-59 12 (41.4) 17 (43.6) 29 (42.6)
60-79 2 (6.9) 1 (2.6) 3 (4.4)
BMI Underweight 1 (3.4) 1 (2.6) 2 (2.9) 0.733
Normal 15 (51.7) 18 (46.2) 33 (48.5)
Overweight 10 (34.5) 12 (30.8) 22 (32.4)
Obese 3 (10.3) 8 (20.5) 11 (16.2)
WC Low risk 14 (48.3) 4 (10.3) 18 (26.5) 0.000
Increased risk 9 (31) 6 (15.4) 15 (22)
Substantially increased risk 6 (20.7) 29 (74.4) 35 (51.5)
WHR Low risk 9 (31) 9 (23.1) 18 (26.5) 0.462
Substantially increased risk 20 (69) 30 (76.9) 50 (73.5)
WHtR Low risk 5 (17.2) 3 (7.7) 8 (11.8) 0.014
Increased risk 19 (65.6) 16 (41) 35 (51.5)
Substantially increased risk 5 (17.2) 20 (51.3) 25 (36.7)
BFP* Normal 5 (17.2) 5 (12.8) 10 (14.7) 0.011
Over weight 6 (20.7) 22 (56.4) 28 (41.2)
Obese 18 (62.1) 12 (30.8) 30 (44.1)
VFL Low risk 12 (41.4) 28 (71.8) 40 (58.8) 0.018
High risk 12 (41.4) 5 (12.8) 17 (25)
Very high risk 5 (17.2) 6 (15.4) 11 (16.2)
SBP Normal 17 (58.8) 26 (66.7) 43 (63.2) 0.672
Pre-HTN 8 (27.6) 10 (25.6) 18 (26.5)
HTN 4 (13.8) 3 (7.7) 7 (10.3)
DBP Normal 13 (44.8) 31 (79.5) 44 (64.7) 0.013
Pre- HTN 12 (41.4) 6 (15.4) 18 (26.5)
HTN 4 (13.8) 2 (5.1) 6 (8.8)
*The sex adjusted BFP cut off values were considered for each age group.
DBP = diastolic blood pressure, SBP = systolic blood pressure, HTN = hypertension, BFP = Body fat percentage, BMI = body mass index, WC = waist circumference,
WHR = waist-to-hip ratio, WHtR =Waist-to-height ratio, VFL = visceral fat level, N = number, M =male, F = female.
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Risk level according to VFL was found to be high in 25%
(17/68) and very high in 16.2% (11/68) (Table 2).
Table 3 describes the Mean ± SD (95% CI) of the
various anthropometric measurements of participants by
sex. The mean BMI (Kg/m2) of the participants was gen-
erally higher in the study participants, 25.26 ± 4.41
(95% CI, 24.2-26.3). The mean WC and WHR of the
participants were 94.26 ± 10.72 (95% CI, 91.67-96.86)
and 0.91 ± 0.07 (95% CI, 0.89-0.93), respectively. On the
other hand, the mean WHtR was general high (0.579 ±
0.073) with a significant intersex variation (P = 0.008)
(Table 3). There was a significant mean BFP variation
among men and women, as expected. It was found out
to be 26.36 ± 6.00 (95% CI, 24.08-28.64) and 36.51 ± 4.50(95% CI, 35.05-37.97) for men and women, respectively
(P < 0.001) (Table 3).
The mean SBP and DBP of the participants were in
the normal ranges, 118 ± 17.3 (95% CI, 114–122.2) and
77 ± 11.2 (95% CI, 74.27-79.7), respectively (Table 3).
Table 4 also describes the means of the BFP of participants
based on specific age and sex groups in comparison to the
normal range. In all the sex adjusted age groups, the mean
BFP was found to be higher than the respective normal
ranges/cut off values.
Table 5 presents the classification of nutritional status
and risk level to CVDs using different anthropometric
measurements and compares them against BMI. Accord-
ingly, BFP effectively classified 100% (22/22) of the ‘over-
weight’ and 100% (11/11) of the ‘obese’ values according to
Table 3 Mean ± SD (95%CI) of various anthropometric measurements of participants by sex, N = 68 (M = 29, F = 39),
Gondar, Ethiopia
Parameter Male Female Total P value
Mean ± SD (95% CI) Mean ± SD (95% CI) Mean ± SD (95% CI)
Weight (kg) 70.49 ± 10.88 (66.35-74.63) 64.62 ± 12.14 (60.68-68.55) 67.12 ± 11.9 (64.24-70.0) 0.043
Height (cm) 169.52 ± 7.27 (166.75-172.28) 158.28 ± 4.9 (156.69-159.87) 163.07 ± 8.19 (161.09-165.06) 0.000
BMI (kg/m2) 24.59 ± 3.99 (23.07-26.11) 25.77 ± 4.68 (24.25-27.29) 25.27 ± 4.4 (24.2-26.3) 0.277
WC (cm) 93.55 ± 9.21 (90.05-97.05) 94.79 ± 11.81 (90.97-98.62) 94.26 ± 10.72 (91.67-96.86) 0.640
WHR 0.92 ± 0.05 (0.90-0.94) 0.90 ± 0.08 (0.87-0.93) 0.91 ± 0.07 (0.89-0.93) 0.253
WHtR 0.553 ± 0.059 (0.53-0.575) 0.599 ± 0.077 (0.574-0.624) 0.579 ± 0.073 (0.562-0.597) 0.008
BFP 26.36 ± 6.00 (24.08-28.64) 36.51 ± 4.50 (35.05-37.97) 32.18 ± 7.2 2 (30.43-33.93) 0.000
VFL 10.41 ± 5.24 (8.42-12.41) 8.26 ± 5.41 (6.50-10.01) 9.18 ± 5.41 (7.87-10.49) 0.104
SBP (mm Hg) 122.1 ± 18.4 (115.1-129.1) 115 ± 16.1 (110–120) 118 ± 17.3 (114–122.2) 0.092
DBP (mm Hg) 80.8 ± 11.2 (76.5-85) 74.1 ± 10.4 (70.8-77.5) 77 ± 11.2 (74.27-79.7) 0.014
DBP = diastolic blood pressure, SBP = systolic blood pressure, HTN = hypertension, BFP = Body fat percentage, BMI = body mass index, WC = waist circumference,
WHR = waist-to-hip ratio, WHtR =Waist-to-height ratio, VFL = visceral fat level, CVDs = cardiovascular disorders, N = number, M =male, F = female, SD = standard
deviation, CI = confidence interval.
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respectively (P = 0.016). On the other hand, VFL was able
to correctly classify 63.6% (14/22) of the ‘overweight’ and
90.9% (10/11) ‘obese’ values as ‘increased risk/substantially
increased risk’ (P < 0.001) (Table 5).
Risk level classification for CVD with WC enabled to
correctly classify 90.9% (20/22) and 100% (11/11) of the
‘overweight’ and ‘obese’ BMI values as ‘increased risk/
substantially increased risk’ and ‘substantially increased’ ,
respectively (P < 0.001) (Table 5).
Risk level classification with WHR was effective in clas-
sifying 68.2% (15/22) and 90.9% of ‘overweight’ and ‘obese’
BMI cases as ‘increased risk’ and ‘increased risk’ , respect-
ively (P = 0.053). On the other end, WHtR was able to
classify 100% (22/22) ‘overweight’ BMI values as ‘increased
risk/substantially increased risk’. It also classified 100%
(11/11) ‘obese’ BMI values as ‘substantially increased risk’
(P < 0.001) (Table 5).
Table 6 presents risk level to CVDs and compares WC,
BFP, VFL, and WHtR with WHR values of participants.
Waist circumference was able to effectively categorize
88% (44/50) of the ‘increased risk’ WHR values asTable 4 Mean ± SD (95%CI) of the body fat percentage of par




20-39 24.84 ± 7.38 (20.75-28.93) 3
40-59 27.61 ± 3.74 (25.23-29.99) 3
60-79 30.25 ± 2.90 (4.20-56.30) 4
*P value = 0.325.
**P value = 0.007.
***Unable to compete SD and CI because there was only one participant in this age
SD = standard deviation, CI = confidence interval.‘increased risk/substantially increased risk’ (P < 0.001).
Likewise, BFP was able to correctly classify 90% (45/50) of
the ‘increased risk/substantially increased’ WHR values as
‘overweight/obese’ (P = 0.051). On the other hand, WHtR
was able to identify 100% (50/50) ‘increased risk’ WHR
values as ‘increased risk/substantially increased risk’
(P < 0.001) (Table 6).
Table 7 presents risk level to CVDs and compares BFP
and VFL with WC values of participants. BFP was able
to effectively categorize 93.3% (14/15) and 94.3% (33/35)
of ‘increased risk’ and ‘substantially increased risk’ WC
values as ‘overweight/obese’ and ‘overweight/obese’ ,
respectively (P < 0.001). VFL, on the contrary, detected
only 46.7% (7/15) and 48.6% (17/35) of the ‘increased
risk’ and ‘substantially increased risk’ WC values as ‘high
risk/very high risk’ (P = 0.035).
Discussion
This study was conducted to evaluate the situation of
HTN and metabolic abnormalities (based on anthropo-
metric measurements only) as a risk factor for CVDs




4.57 ± 4.45 (32.55-36.58) 8-20 20-32
8.54 ± 3.41 (36.78-40.29) 9-22 21-34
2.70*** 11-23 23-35
group.
Table 5 Classification of nutritional status using and comparison of risk level to CVDs using BFP, VFL, WC, and WHR
against BMI, N = 68 (M = 29, F = 39), Gondar, Ethiopia
BMI
Underweight N (%) Normal N (%) Over weight N (%) Obese N (%) Total N (%)
BFP* Normal 1 (50) 9 (27.3) 0 0 10 (14.7)
Overweight 1 (50) 14 (42.4) 10 (45.5) 3 (27.3) 28 (41.2)
Obese 0 10 (30.3) 12 (54.5) 8 (72.7) 30 (44.1)
Total N (%) 2 (2.9) 33 (48.5) 22 (32.4) 11 (16.2) 68 (100)
VFL** Low risk 2 (100) 29 (87.9) 8 (36.4) 1 (9.1) 40 (58.8)
Increased risk 0 4 (12.1) 11 (50) 2 (18.2) 17 (25)
Very increased risk 0 0 3 (13.6) 8 (72.7) 11 (16.2)
Total 2 (2.9) 33 (48.5) 22 (32.4) 11 (16.2) 68 (100)
WC (cm)*** Low risk 2 (100) 14 (42.4) 2 (9.1) 0 18 (26.5)
Increased risk 0 8 (24.3) 7 (31.8) 0 15 (22)
Substantially increased risk 0 11 (33.3) 13 (59.1) 11 (100) 35 (51.5)
Total N (%) 2 (2.9) 33 (48.5) 22 (32.4) 11 (16.2) 68 (100)
WHR**** Low risk 2 (100) 8 (24.4) 7 (31.8) 1 (9.1) 18 (26.5)
Increased risk 0 25 (75.6) 15 (68.2) 10 (90.9) 50 (73.5)
Total 2 (2.9) 33 (48.5) 22 (32.4) 11 (16.2) 68 (100)
WHtR***** Low risk 2 (100) 6 (18.2) 0 0 8 (11.8)
Increased risk 0 22 (66.7) 13 (59.1) 0 35 (51.5)
Substantially increased risk 0 5 (15.1) 9 (40.9) 11 (100) 25 (36.8)
Total N (%) 2 (2.9) 33 (48.5) 22 (32.4) 11 (16.2) 68 (100)
*Pearson’s Chi Square = 15.65, P = 0.016 , **Pearson’s chi square = 47.71, P = 0.000, ***Pearson’s, chi square = 24.99, P = 0.000, ****Pearson’s chi square = 7.67,
P = 0.053, *****Pearson’s chi square = 43.69, P = 0.000.
BFP = Body fat percentage, BMI = body mass index, WC = waist circumference, WHR = waist-to-hip ratio, WHtR =Waist-to-height ratio, VFL = visceral fat level,
CVDs = cardiovascular disorders, N = number, M =male, F = female.
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10.3% among women based on raised SBP (> = 140 mm
Hg) and DBP (> = 9 0 mm Hg). A study conducted among
adults in Addis Ababa reported a prevalence of 31.5% for
men and 28.9% for women [8] which is much higher than
found in this study. Similarly, the WHO estimated the
prevalence of HTN in Ethiopia for the year 2008 to be
35.2%, way too much higher than in the current study.
The estimates for sex adjusted prevalence were also much
higher, 37.3% and 33.2% among males and females,
respectively [15]. Nevertheless, the prevalence of HTN in
the current study is well above that of a study conducted
in the mid 1990s which reported a prevalence of 7.1%
even though the study was conducted among young adults
only [7]. The current finding underscores the need of fur-
ther survey incorporating large segment of the population.
The increasing prevalence of HTN, as frequently reported,
could be due to unhealthy diet, harmful use of alcohol,
lack of physical activity, excess weight and exposure to
persistent stress [16-19].
A rather intriguing finding in the current study was,
according to BMI measurements, a high prevalence of
overweight (32.4%) and obesity (16.2%). The sex adjusted
prevalence of overweight was also very high (34.5% formen and 30.8% for women) with small variation (P > 0.05).
On the other hand, the prevalence of obesity among men
and women in the current study were 10.3% and 20.5%.
There were more obese women but the variation was not
statistically significant (P > 0.05). According to the WHO,
the estimated prevalence of overweight was 7.4% in 2008
much lower than the figures in this study. Similarly, the
estimates for men and women were also much lower with
6.2% and 8.6%, respectively. The estimated prevalence of
obesity was also by far very low according to the WHO,
1.1%; only 0.7% among men and 1.5% among women [15].
On the other hand, in comparison to the report in Addis
Ababa (20.2% for men and 37.7% for women), overweight
was more prevalent in Gondar among men and less preva-
lent among women [8]. The prevalence of overweight in
the current study was several times higher than the one
reported from three demographic surveillance sites in
Ethiopia (2.5 and 2.2% among men and women) [20].
These figures will be more intriguing when nutritional
status is defined based on the total body fat percentage
(BFP) which reported a 41.2% of overweight and 44.1%
of obesity in the study population. The BFP classified
more men as obese (62.1%) than women (30.8%)
whereas it classified more women as overweigh (56.4%)
Table 7 Comparison of risk level to CVDs using BFP and VFL against WC, N = 68 (M = 29, F = 39), Gondar, Ethiopia
WC (cm)
Low risk N (%) Increased risk N (%) Substantially increased risk Total N (%)
BFP* Normal 7 (38.9) 1 (6.7) 2 (5.7) 10 (14.7)
Overweight 5 (27.8) 8 (53.3) 15 (42.9) 28 (41.2)
Obese 6 (33.3) 6 (40) 18 (51.4) 30 (44.1)
Total N (%) 18 (26.5) 15 (22.1) 35 (51.5) 68 (100)
VFL** Low risk 14 (77.8) 8 (53.3) 18 (51.4) 40 (58.8)
High risk 4 (22.2) 6 (40) 7 (20) 17 (25)
Very high risk 0 1 (6.7) 10 (28.6) 11 (16.2)
Total N (%) 18 (26.5) 15 (22.1) 35 (51.5) 68 (100)
WHtR*** Low risk 8 (44.4) 0 0 8 (11.8)
Increased risk 10 (55.6) 15 (100) 10 (28.6) 35 (51.5)
Substantially increased risk 0 0 25 (71.4) 25 (36.7)
Total N (%) 18 (26.5) 15 (22.1) 35 (51.5) 68 (100)
*Pearson’s chi square = 12.05, P = 0.017.
**Pearson’s chi square = 10.33, P = 0.035.
***Pearson’s chi square = 56.28, P = 0.000.
BFP = Body fat percentage, WC =Waist circumference, WHtR =Waist-to-height ratio, VFL = Visceral fat level, CVDs = Cardiovascular disorders, N = number,
M =male, F = female.
Table 6 Comparison of risk level to CVDs using WC, BFP and VFL against WHR of participants, N = 68 (M = 29, F = 39),
Gondar, Ethiopia
WHR
Low risk N (%) Increased risk N (%) Total N (%)
WC (cm)* Low risk 12 (66.6) 6 (12) 18 (26.5)
Increased risk 3 (16.7) 12 (24) 15 (22)
Substantially increased risk 3 (16.7) 32 (64) 35 (51.5)
Total N (%) 18 (26.5) 50 (73.5) 68 (100)
WHtR** Low risk 8 (44.4) 0 8 (11.8)
Increased risk 8 (44.4) 27 (54) 35 (51.5)
Substantially increased risk 2 (11.2) 23 (46) 25 (36.8)
Total N (%) 18 (26.5) 50 (73.5) 68 (100)
BFP*** Normal 5 (27.8) 5 (10) 10 (14.7)
Overweight 9 (50) 19 (38) 28 (41.2)
Obese 4 (22.2) 26 (52) 30 (44.1)
Total 18 (26.5) 50 (73.5) 68 (100)
VFL**** Low risk 13 (72.2) 27 (54) 40 (58.8)
High risk 4 (22.2) 13 (26) 17 (25)
Very high risk 1 (5.6) 10 (20) 11 (16.2)
Total N (%) 18 (26.5) 50 (73.5) 68 (100)
*Pearson’s chi square = 21.03, P = 0.000.
**Pearson’s chi square = 26.84, P = 0.000.
***Pearson’s chi square = 5.97, P = 0.051.
****Pearson’s chi square = 21.03, P = 0.282.
BFP = Body fat percentage, WC = waist circumference, WHR =Waist-to-hip ratio, WHtR =Waist-to-height ratio, VFL = Visceral fat level, CVDs = Cardiovascular
disorders, N = number, M =male, F = female.
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http://www.biomedcentral.com/1471-2261/14/155than men (20.7%). There was a significant nutritional
status variation across gender (P = 0.011) (Table 3). Even
though the current study was conducted in a smaller
section of randomly selected adults, the figures are not
quite ignorable. Hence, demand further study and
intervention.
There are a number of grave and chronic consequences
(CVDs including HTN, DM and cancer) of being over-
weight or obese. Sixty-three per cent (63%) of global
deaths in 2008 (i.e. 36 million of the 57 million global
deaths) resulted from non communicable diseases, princi-
pally CVDs, DM, and cancers [21]. To make matters
worse, nearly 80% (28 million) of these deaths were be-
lieved to have occurred in low- and middle-income coun-
tries. Therefore, underlying causes/factors and potential
associated risks of the prevalent obesity and overweight in
the current study require fair attention to plan a proper
intervention.
Even though BMI is commonly used as a measure of
overall adiposity and classify risk level to various chronic
illnesses [22-25], growing evidence suggests that a cen-
tral (abdominal) fat distribution pattern, as reflected by a
higher WC or WHR might be a better measure of risk
[26-34]. In this study, based on measurements of WC,
the risk of developing CVDs was rated to be increased
or substantially increased (men >94 cm and >102 cm;
women >80 cm and >88 cm) in more than half of the
men (51.7%) and majority of the women (with women
more likely to have central obesity than men, P < 0.001).
On the other hand, based on measurements of WHR,
69% of men and 76.9% of women were found to have
increased risks (men > = 0.90, women > = 0.85) of devel-
oping CVDs without significant difference across gender
(P = 0.462). This quite high figure demands a large scale
study to define the cut off values.
There is growing evidence to use the WHTR as a
more sensitive measurement than BMI as an early warn-
ing of health risks [35,36]. It is also reported WHTR
could be more closely associated with central obesity
than BMI [37] and even better than WC as it encom-
passes the adjustment to different statures [38,39]. The
risk level in the current study was rated to be either in-
creased (WHtR > = 0.50) or substantially increased
(WHtR > = 0.60) in 88.2% of the participants. The risk
level across gender was also increased/substantially in-
creased with WHtR of 82.8% and 92.3% among men and
women, respectively, with women to have more central
obesity than men (0.014). On the contrary, general risk
level according to VFL was found to be either increased
or substantially increased in 41.2%; 58.6% men and
28.2% women (p = 0.018).
In the current study, the sex adjusted mean SBP (mm
Hg) was 122.1 (115.1-129.1) and 115 (110–120) among
men and women, respectively which is much lower incomparison to the one reported in Addis Ababa which
showed a mean SBP of 129.4 mmHg (128.4-130.5)
among males and 126.2 mmHg (125.1-127.2) among
females [8]. On the other hand, the mean DBP (mmHg)
in the current study among men 80.8 (76.5-85) was in
agreement the one reported in Addis Ababa 81.2 mmHg
(80.6-81.9) [8]. However, the mean DBP (mm Hg)
among women 74.1 (70.8-77.5) in this study was lower
than that of the report from Addis Ababa 80.0 mmHg
(79.5-80.6) [8]. On the contrary, the mean SBP and DBP
in the current study were higher than reported else-
where in Ethiopia [20].
In this study, it was observed that the mean BMI (Kg/m2)
(95% CI) of the participants was generally higher, 25.26
(24.2-26.3). There was not significant variation of mean
BMI (kg/m2) among men and women (0.227), 24.59 (23.07-
26.11) and 25.77 (24.25-27.29), respectively. However, the
mean remained high. On the contrary, there was a signifi-
cant variation in the mean weights and heights of women
and men. The mean (95% CI) of weight (kg) was calculated
to be 70.49 (66.35-74.63) and 64.62 (60.68-68.55) for men
and women, respectively (P = 0.043). Similarly, the mean
(95% CI) height (cm) was computed to be 169.52 (166.75-
172.28) and 158.28 (156.69-159.87) for men and women,
respectively (P < 0.001). The mean BMI (kg/m2) and weight
(kg) in the current study were much higher than the
respective figures reported elsewhere in Ethiopia while the
mean height (cm) was in harmony [20].
Another interesting finding from this study was a
higher mean (95% CI) WC of the participants 94.26
(91.67-96.86). Even if the mean WC of the participants
didn’t significantly vary among sex groups, [93.55
(90.05-97.05) and 94.79 (90.97-98.62) among men and
women, respectively] the mean value for women was
much higher than the respective cut off. On the other
hand, the mean WHtR was generally high (0.579) with a
significant intersex variation (P = 0.008). Likewise, the
mean age adjusted BFP was higher than the expected cut
off values for both men. Besides, there was a significant
mean BFP variation across the three age groups among
women (P = 0.007).
In this study, it was attempted to compare the various
anthropometric measurements against BMI. Even though
there is not one gold standard anthropometric measure-
ment to classify risk level, BMI, WC and WHR were used
as ‘standard’. Accordingly, BFP was able to effectively clas-
sify all of the ‘overweight’ and the ‘obese’ values based on
the BMI as ‘overweight/obese’. Besides, BFP was able to
detect 25 additional ‘overweight or obese’ cases missed by
the BMI (P = 0.016). Likewise, risk level classification with
WC was able to correctly classify most (20/22) of the
‘overweight’ and all of the ‘obese’ BMI values as ‘increased
risk and/or substantially increased risk. It was also able to
detect 19 more ‘increased risk and/or substantially
Moges et al. BMC Cardiovascular Disorders 2014, 14:155 Page 9 of 10
http://www.biomedcentral.com/1471-2261/14/155increased’ cases (P < 0.001) than the BMI. Similarly, WHtR
was able to classify all the ‘overweight’ and ‘obese’ BMI
values as ‘increased risk and/or substantially increased
risk’. In addition to this, it was able to detect 27 more
‘increased risk and/or substantially increased risk’ cases
missed by the BMI (P < 0.001).
On the contrary, VFL was able to correctly classify only
63.6% (14/22) of the ‘overweight’ and 90.9% (10/11) ‘obese’
values as ‘increased risk/substantially increased risk’. Apart
from this, VFL misclassified 9 ‘overweight/obese’ cases
detected by the BMI (P < 0.001). Similarly, risk level classi-
fication with WHR was effective in classifying only 68.2%
(15/22) and 90.9% (10/11) of ‘overweight’ and ‘obese’ BMI
cases as ‘increased risk’. It also missed 8 ‘overweight/
obese’ cases (P = 0.053) detected by the BMI. It is evident
that in all of the anthropometric measurements compared
with BMI, they were able to detect nearly all obese cases.
Nevertheless, further study is required to substantiate this
assumption. On the other hand, WHtR, BFP, WC, and
VFL were able to effectively categorize 50, 45, 44, and 23
of the 50 ‘increased risk’ WHR values as ‘increased risk/
substantially increased risk’ , respectively. Besides, WHtR,
BFP, WC, and VFL were able to detect 8, 13, 3, and 5
additional ‘increased risk/substantially increased risk’
cases, respectively.
When WHtR, BFP and VFL were compared with WC
values, WHtR was able to correctly classify all ‘increased
risk/substantially increased’ WC values. It also detected
10 additional ‘increased risk’ cases (P < 0.001). On the
other hand, BFP was able to effectively categorize 14/15
and 33/35 of ‘increased risk’ and ‘substantially increased
risk’ WC values as ‘overweight/obese’ (P < 0.001). VFL,
on the contrary, detected only 7/15) and 17/35 of the
‘increased risk’ and ‘substantially increased risk’ WC
values as ‘high risk/very high risk’ (P = 0.035). So far,
WHtR seems to be the most efficient anthropometric
measurement to strongly agree with the other anthropo-
metric measurements though large scale studies are
required to substantiate this finding.
The current study couldn’t outline whether certain
anthropometric values were associated with HTN, DM,
cancer, or other chronic diseases and biochemical pa-
rameters were not collected as well. This obviates the
need of a longitudinal study in the country.
The small sample size was a major limitation of the
study; results must be interpreted with caution. The
study was carried out in only one city of Northwest
Ethiopia and thus the finding cannot be generalized to
HTN in Ethiopia. Its cross-sectional design was also
limited in evaluating cause-and-effect associations.
Conclusion
In conclusion, the current study was able to detect a
high prevalence of overweight, obesity, and HTN amongadult population in Gondar town. The mean BMI of the
participants was in the range of overweight values. There
is a prevalent high level of general adiposity evidenced
by the high BFP in all age groups and sexes. The central
obesity as measured by WC, WHR, WHtR and VFL was
also very high. Even though there is a need of large scale
study in the country to set national cut off values to effi-
ciently level risk groups, WHtR and BFP were the most
efficient measurements to identify nearly all ‘high risk’
groups of individuals as ‘high risk’ irrespective of their
gender. The VFL, in contrary, was unable to identify
quite a significant number of ‘high risk’ groups. In gen-
eral, both general adiposity, captured by BMI or BFP,
and abdominal adiposity, captured by WC, WHR, WHtR
or VFL could independently be risk factors for certain
diseases. Therefore, it is important to elucidate the
mechanisms and independent roles of body fat distribu-
tion on the etiology of chronic diseases.
Despite the fact that the study wasn’t conducted on a
large sample size population and evenly distributed age
and sex groups, the findings of the study can alarm that a
salient but an unnoticed epidemics of non-communicable
diseases in northwest Ethiopia and beyond. Even if the
most important risk factors could be similar with other
populations in the world, it is mandatory to specifically
identify the most important risk factors in order to plan a
public health control program.
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